These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 8223912

  • 1. Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase.
    Törnwall M, Tuomainen P, Männistö PT.
    Eur J Pharmacol; 1993 Aug 03; 239(1-3):39-45. PubMed ID: 8223912
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.
    Männistö PT, Tuomainen P, Tuominen RK.
    Br J Pharmacol; 1992 Mar 03; 105(3):569-74. PubMed ID: 1628144
    [Abstract] [Full Text] [Related]

  • 5. Effects of peripheral and central catechol-O-methyltransferase inhibition on striatal extracellular levels of dopamine: a microdialysis study in freely moving rats.
    Napolitano A, Bellini G, Borroni E, Zürcher G, Bonuccelli U.
    Parkinsonism Relat Disord; 2003 Jan 03; 9(3):145-50. PubMed ID: 12573869
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of intracerebral 6-nitronoradrenaline, an endogenous catechol-O-methyltransferase (COMT) inhibitor, on striatal dopamine metabolism in anaesthetised rats.
    Huotari M, Passlin M, Nordberg HL, Forsberg M, Kotisaari S, Tuomisto L, Shintani F, Tanaka KF, Reenilä I, Laitinen K, Männistö PT.
    J Neurosci Methods; 2001 Aug 15; 109(1):47-52. PubMed ID: 11489299
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Catechol-O-methyltransferase inhibition increases striatal L-dopa and dopamine: an in vivo study in rats.
    Brannan T, Martínez-Tica J, Yahr MD.
    Neurology; 1992 Mar 15; 42(3 Pt 1):683-5. PubMed ID: 1549240
    [Abstract] [Full Text] [Related]

  • 10. The central catechol-O-methyltransferase inhibitor tolcapone increases striatal hydroxyl radical production in L-DOPA/carbidopa treated rats.
    Gerlach M, Xiao AY, Kuhn W, Lehnfeld R, Waldmeier P, Sontag KH, Riederer P.
    J Neural Transm (Vienna); 2001 Mar 15; 108(2):189-204. PubMed ID: 11314772
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study.
    Kaakkola S, Wurtman RJ.
    Brain Res; 1992 Aug 07; 587(2):241-9. PubMed ID: 1381981
    [Abstract] [Full Text] [Related]

  • 15. No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats.
    Li YH, Wirth T, Huotari M, Laitinen K, MacDonald E, Männistö PT.
    Eur J Pharmacol; 1998 Sep 04; 356(2-3):127-37. PubMed ID: 9774242
    [Abstract] [Full Text] [Related]

  • 16. The role of physicochemical properties of entacapone and tolcapone on their efficacy during local intrastriatal administration.
    Forsberg MM, Huotari M, Savolainen J, Männistö PT.
    Eur J Pharm Sci; 2005 Apr 04; 24(5):503-11. PubMed ID: 15784340
    [Abstract] [Full Text] [Related]

  • 17. CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure.
    Waldmeier PC, Baumann PA, Feldtrauer JJ, Hauser K, Bittiger H, Bischoff S, von Sprecher G.
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Sep 04; 342(3):305-11. PubMed ID: 1980718
    [Abstract] [Full Text] [Related]

  • 18. Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone.
    Nissinen E, Lindén IB, Schultz E, Pohto P.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep 04; 346(3):262-6. PubMed ID: 1407012
    [Abstract] [Full Text] [Related]

  • 19. Different modes of action of catecholamine-O-methyltransferase inhibitors entacapone and tolcapone on adenylyl cyclase activity in vitro.
    Gerlach M, Ukai W, Ozawa H, Riederer P.
    J Neural Transm (Vienna); 2002 May 04; 109(5-6):789-95. PubMed ID: 12111468
    [Abstract] [Full Text] [Related]

  • 20. Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats.
    Huotari M, Gainetdinov R, Männistö PT.
    Pharmacol Toxicol; 1999 Nov 04; 85(5):233-8. PubMed ID: 10608486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.